메뉴 건너뛰기




Volumn 155, Issue 3, 2011, Pages 328-339

KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells and osteoclasts

Author keywords

Apoptosis; Multiple myeloma; Osteoclast; Severe combined immunodeficient mouse; Spicamycin

Indexed keywords

6 [4 DEOXY 4 (2,4 TETRADECADIENOYLGLYCYLAMINO) GLYCERO BETA MANNOHEPTOPYRANOSYLAMINO] 9H PURINE;

EID: 80053987418     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08844.x     Document Type: Article
Times cited : (5)

References (41)
  • 1
    • 0037105599 scopus 로고    scopus 로고
    • Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma
    • Abe, M., Hiura, K., Wilde, J., Moriyama, K., Hashimoto, T., Ozaki, S., Wakatsuki, S., Kosaka, M., Kido, S., Inoue, D. & Matsumoto, T. (2002) Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. Blood, 100, 2195-2202.
    • (2002) Blood , vol.100 , pp. 2195-2202
    • Abe, M.1    Hiura, K.2    Wilde, J.3    Moriyama, K.4    Hashimoto, T.5    Ozaki, S.6    Wakatsuki, S.7    Kosaka, M.8    Kido, S.9    Inoue, D.10    Matsumoto, T.11
  • 3
    • 33846031926 scopus 로고    scopus 로고
    • The molecular understanding of osteoclast differentiation
    • Asagiri, M. & Takayanagi, H. (2007) The molecular understanding of osteoclast differentiation. Bone, 40, 251-264.
    • (2007) Bone , vol.40 , pp. 251-264
    • Asagiri, M.1    Takayanagi, H.2
  • 4
    • 77949894706 scopus 로고    scopus 로고
    • Long-term follow-up of autotransplantation trials for multiple myeloma: update of protocols conducted by the intergroupe francophone du myelome, southwest oncology group, and university of arkansas for medical sciences
    • Barlogie, B., Attal, M., Crowley, J., van Rhee, F., Szymonifka, J., Moreau, P., Durie, B.G. & Harousseau, J.L. (2010) Long-term follow-up of autotransplantation trials for multiple myeloma: update of protocols conducted by the intergroupe francophone du myelome, southwest oncology group, and university of arkansas for medical sciences. Journal of Clinical Oncology, 28, 1209-1214.
    • (2010) Journal of Clinical Oncology , vol.28 , pp. 1209-1214
    • Barlogie, B.1    Attal, M.2    Crowley, J.3    van Rhee, F.4    Szymonifka, J.5    Moreau, P.6    Durie, B.G.7    Harousseau, J.L.8
  • 7
    • 0037804761 scopus 로고    scopus 로고
    • KRN5500: a novel therapeutic agent with in vitro activity against human B-cell chronic lymphocytic leukemia cells mediates cytotoxicity via the intrinsic pathway of apoptosis
    • Byrd, J.C., Lucas, D.M., Mone, A.P., Kitner, J.B., Drabick, J.J. & Grever, M.R. (2003) KRN5500: a novel therapeutic agent with in vitro activity against human B-cell chronic lymphocytic leukemia cells mediates cytotoxicity via the intrinsic pathway of apoptosis. Blood, 101, 4547-4550.
    • (2003) Blood , vol.101 , pp. 4547-4550
    • Byrd, J.C.1    Lucas, D.M.2    Mone, A.P.3    Kitner, J.B.4    Drabick, J.J.5    Grever, M.R.6
  • 8
    • 34948890040 scopus 로고    scopus 로고
    • Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells
    • Davenport, E.L., Moore, H.E., Dunlop, A.S., Sharp, S.Y., Workman, P., Morgan, G.J. & Davies, F.E. (2007) Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells. Blood, 110, 2641-2649.
    • (2007) Blood , vol.110 , pp. 2641-2649
    • Davenport, E.L.1    Moore, H.E.2    Dunlop, A.S.3    Sharp, S.Y.4    Workman, P.5    Morgan, G.J.6    Davies, F.E.7
  • 9
    • 0037072533 scopus 로고    scopus 로고
    • A water-soluble synthetic spicamycin derivative (San-Gly) decreases mechanical allodynia in a rodent model of neuropathic pain
    • DiLorenzo, L., Kobierski, L., Moore, K.A. & Borsook, D. (2002) A water-soluble synthetic spicamycin derivative (San-Gly) decreases mechanical allodynia in a rodent model of neuropathic pain. Neuroscience Letters, 330, 37-40.
    • (2002) Neuroscience Letters , vol.330 , pp. 37-40
    • DiLorenzo, L.1    Kobierski, L.2    Moore, K.A.3    Borsook, D.4
  • 11
    • 0023159808 scopus 로고
    • Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains
    • Elbein, A.D. (1987) Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Annual Review of Biochemistry, 56, 497-534.
    • (1987) Annual Review of Biochemistry , vol.56 , pp. 497-534
    • Elbein, A.D.1
  • 12
    • 0021033184 scopus 로고
    • Studies on the differentiation inducers of myeloid leukemic cells. III. Spicamycin, a new inducer of differentiation of HL-60 human promyelocytic leukemia cells
    • Hayakawa, Y., Nakagawa, M., Kawai, H., Tanabe, K., Nakayama, H., Shimazu, A., Seto, H. & Otake, N. (1983) Studies on the differentiation inducers of myeloid leukemic cells. III. Spicamycin, a new inducer of differentiation of HL-60 human promyelocytic leukemia cells. The Journal of antibiotics (Tokyo), 36, 934-937.
    • (1983) The Journal of antibiotics (Tokyo) , vol.36 , pp. 934-937
    • Hayakawa, Y.1    Nakagawa, M.2    Kawai, H.3    Tanabe, K.4    Nakayama, H.5    Shimazu, A.6    Seto, H.7    Otake, N.8
  • 15
    • 0029797131 scopus 로고    scopus 로고
    • Inhibitory effect of a spicamycin derivative, KRN5500, on the growth of hepatic metastasis of human colon cancer-producing tissue polypeptide antigen
    • Kamishohara, M., Kawai, H., Sakai, T., Uchida, T., Tsuruo, T. & Otake, N. (1996) Inhibitory effect of a spicamycin derivative, KRN5500, on the growth of hepatic metastasis of human colon cancer-producing tissue polypeptide antigen. Cancer Chemotherapy and Pharmacology, 38, 495-498.
    • (1996) Cancer Chemotherapy and Pharmacology , vol.38 , pp. 495-498
    • Kamishohara, M.1    Kawai, H.2    Sakai, T.3    Uchida, T.4    Tsuruo, T.5    Otake, N.6
  • 16
    • 0034192203 scopus 로고    scopus 로고
    • Selective accumulation of the endoplasmic reticulum-Golgi intermediate compartment induced by the antitumor drug KRN5500
    • Kamishohara, M., Kenney, S., Domergue, R., Vistica, D.T. & Sausville, E.A. (2000) Selective accumulation of the endoplasmic reticulum-Golgi intermediate compartment induced by the antitumor drug KRN5500. Experimental Cell Research, 256, 468-479.
    • (2000) Experimental Cell Research , vol.256 , pp. 468-479
    • Kamishohara, M.1    Kenney, S.2    Domergue, R.3    Vistica, D.T.4    Sausville, E.A.5
  • 17
    • 0034161257 scopus 로고    scopus 로고
    • KRN5500, a novel antitumor agent, induces apoptosis or cell differentiation in HL-60 cells
    • Kawasaki, K., Murakami, T., Ita, M., Sasaki, K. & Furukawa, S. (2000) KRN5500, a novel antitumor agent, induces apoptosis or cell differentiation in HL-60 cells. Cytometry, 39, 211-216.
    • (2000) Cytometry , vol.39 , pp. 211-216
    • Kawasaki, K.1    Murakami, T.2    Ita, M.3    Sasaki, K.4    Furukawa, S.5
  • 18
    • 42449114035 scopus 로고    scopus 로고
    • Multiple myeloma
    • Kyle, R.A. & Rajkumar, S.V. (2008) Multiple myeloma. Blood, 111, 2962-2972.
    • (2008) Blood , vol.111 , pp. 2962-2972
    • Kyle, R.A.1    Rajkumar, S.V.2
  • 19
    • 0028913674 scopus 로고
    • In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines
    • Lee, Y.S., Nishio, K., Ogasawara, H., Funayama, Y., Ohira, T. & Saijo, N. (1995) In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines. Cancer Research, 55, 1075-1079.
    • (1995) Cancer Research , vol.55 , pp. 1075-1079
    • Lee, Y.S.1    Nishio, K.2    Ogasawara, H.3    Funayama, Y.4    Ohira, T.5    Saijo, N.6
  • 22
    • 33744539521 scopus 로고    scopus 로고
    • Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
    • Obeng, E.A., Carlson, L.M., Gutman, D.M., Harrington, Jr, W.J., Lee, K.P. & Boise, L.H. (2006) Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood, 107, 4907-4916.
    • (2006) Blood , vol.107 , pp. 4907-4916
    • Obeng, E.A.1    Carlson, L.M.2    Gutman, D.M.3    Harrington Jr., W.J.4    Lee, K.P.5    Boise, L.H.6
  • 25
    • 34250899722 scopus 로고    scopus 로고
    • Signal integration in the endoplasmic reticulum unfolded protein response
    • Ron, D. & Walter, P. (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nature Reviews. Molecular Cell Biology, 8, 519-529.
    • (2007) Nature Reviews. Molecular Cell Biology , vol.8 , pp. 519-529
    • Ron, D.1    Walter, P.2
  • 29
    • 0034284212 scopus 로고    scopus 로고
    • KRN5500 induces apoptosis (PCD) of myeloid leukemia cell lines and patient blasts
    • Stine, K.C., Warren, B.A., Saylors, R.L. & Becton, D.L. (2000) KRN5500 induces apoptosis (PCD) of myeloid leukemia cell lines and patient blasts. Leukemia Research, 24, 741-749.
    • (2000) Leukemia Research , vol.24 , pp. 741-749
    • Stine, K.C.1    Warren, B.A.2    Saylors, R.L.3    Becton, D.L.4
  • 30
    • 0242525649 scopus 로고    scopus 로고
    • Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors
    • Supko, J.G., Eder, Jr, J.P., Ryan, D.P., Seiden, M.V., Lynch, T.J., Amrein, P.C., Kufe, D.W. & Clark, J.W. (2003) Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors. Clinical Cancer Research, 9, 5178-5186.
    • (2003) Clinical Cancer Research , vol.9 , pp. 5178-5186
    • Supko, J.G.1    Eder Jr., J.P.2    Ryan, D.P.3    Seiden, M.V.4    Lynch, T.J.5    Amrein, P.C.6    Kufe, D.W.7    Clark, J.W.8
  • 32
    • 0035040920 scopus 로고    scopus 로고
    • Population pharmacokinetic modeling and model validation of a spicamycin derivative, KRN5500, in phase 1 study
    • Takama, H., Tanaka, H., Sudo, T., Tamura, T. & Tanigawara, Y. (2001) Population pharmacokinetic modeling and model validation of a spicamycin derivative, KRN5500, in phase 1 study. Cancer Chemotherapy and Pharmacology, 47, 404-410.
    • (2001) Cancer Chemotherapy and Pharmacology , vol.47 , pp. 404-410
    • Takama, H.1    Tanaka, H.2    Sudo, T.3    Tamura, T.4    Tanigawara, Y.5
  • 38
    • 8844264524 scopus 로고    scopus 로고
    • The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells
    • Yata, K. & Yaccoby, S. (2004) The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells. Leukemia, 18, 1891-1897.
    • (2004) Leukemia , vol.18 , pp. 1891-1897
    • Yata, K.1    Yaccoby, S.2
  • 39
    • 32644432826 scopus 로고    scopus 로고
    • pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response
    • Yoshida, H., Oku, M., Suzuki, M. & Mori, K. (2006) pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response. Journal of Cell Biology, 172, 565-575.
    • (2006) Journal of Cell Biology , vol.172 , pp. 565-575
    • Yoshida, H.1    Oku, M.2    Suzuki, M.3    Mori, K.4
  • 41
    • 0037085778 scopus 로고    scopus 로고
    • Myeloid cell factor-1 is a critical survival factor for multiple myeloma
    • Zhang, B., Gojo, I. & Fenton, R.G. (2002) Myeloid cell factor-1 is a critical survival factor for multiple myeloma. Blood, 99, 1885-1893.
    • (2002) Blood , vol.99 , pp. 1885-1893
    • Zhang, B.1    Gojo, I.2    Fenton, R.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.